Metabolic bone disease
Mary Nakamura, MD
UCSF/SFVAHCS
San Francisco, CA, United States
Disclosure(s): No financial relationships with ineligible companies to disclose
Julia Charles, MD, PhD
Brigham and Women's Hospital
Boston, MA, United States
Disclosure(s): Ultragenyx: Advisor or Review Panel Member (Ongoing)
Osteoporosis remains a highly prevalent condition that results from multiple mechanisms. This session will highlight recent studies examining the molecular mechanisms that lead to osteoporosis.
Speaker: Ling QIN, PhD – University of Pennsylvania
Speaker: Roberto Pacifici, MD – Emory University
Speaker: Melissa Kacena, PhD – Indiana University School of Medicine